Correction: Dolutegravir/Abacavir/Lamivudine versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study. Issue 5 (July 2017)

Record Type:
Journal Article
Title:
Correction: Dolutegravir/Abacavir/Lamivudine versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study. Issue 5 (July 2017)
Main Title:
Correction: Dolutegravir/Abacavir/Lamivudine versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study
Authors:
Trottier, Benoît
Lake, Jordan E
Logue, Ken
Brinson, Cynthia
Santiago, Lizette
Brennan, Clare
Koteff, Justin A
Wynne, Brian
Hopking, Judy
Granier, Catherine
Aboud, Michael
Abstract:
Is Part Of:
Antiviral therapy. Volume 22:Issue 5(2017)
Journal:
Antiviral therapy
Issue:
Volume 22:Issue 5(2017)
Issue Display:
Volume 22, Issue 5 (2017)
Year:
2017
Volume:
22
Issue:
5
Issue Sort Value:
2017-0022-0005-0000
Page Start:
459
Page End:
460
Publication Date:
2017-07
Subjects:
Antiviral agents -- Periodicals
Antiviral Agents -- therapeutic use
Virus Diseases -- therapy
Viruses -- drug effects
Antiviral agents
Periodical
Electronic journals
Periodicals
616.9106
Journal URLs:
http://www.intmedpress.com/General/showSectionSub.cfm?SectionID=2&SectionSubID=1&SectionSubSubID=1 ↗
http://www.uk.sagepub.com/home.nav ↗
DOI:
10.3851/IMP3192 ↗
Languages:
English
ISSNs:
1359-6535
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
17216.xml